CIK 0001501796 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aura Biosciences, Inc.
Sign in to watch- Ticker
- AURA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 320271970
- Phone
- (617)500-8864
- Business address
- 80 GUEST STREET, BOSTON, MA, 02135
- 4 Open-market sale 10% owner sold 6,922,870 shares at $5.64 ($39,044,987)
- 10-Q Report Quarterly Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations · Other events
- 3 Insider Initial Statement of Ownership
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Material agreement · Results of operations · Other events
- DEFA14A Proxy Proxy Materials
- S-3MEF Other S-3MEF
- 424B5 Offering Prospectus
- 8-K Event Executive or director change · Regulation FD disclosure · Other events
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 144 Insider Sale of Securities
- 4 Open-market sale See Remarks sold 11,738 shares at $7.02 ($82,401)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations · Other events
Page 3 of 20 · 383 filings